Can Takeda&39;s Alunbrig Take On Roche&39;s Alecensa In FirstLine ALKPositive Lung Cancer

Takeda&39;s Phase III win over Pfizer&39;s Xalkori leaves oncologists cheering but hankering for a headtohead study against Alecensa which is...&160;&160;